Overview

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Assess the effect of renal function on the blood levels of DCV, ASV, BMS-791325.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Asunaprevir